SOLARA ACTIVE PHARMA SCIENCES LIMITED — Capital/Financing Update 2025

Mar 26, 2025

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

March 26, 2025

The BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 541540, 890202 Symbol: SOLARA, SOLARAPP

Dear Sir/Madam,

Sub: Intimation under Regulation 30 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of Rights Issue Committee Meeting dated March 26, 2025

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘ SEBI Listing Regulations ’), this is to inform that the Rights Issue Committee of the Board of Directors of the Company at its meeting held on Wednesday, March 26, 2025 has approved the making of first call of ₹ 3.50/- each (i.e.) 35% on the face value (“ FV ”) of Rs. 10/- each on the outstanding 1,19,98,755 (One Crore Nineteen Lakhs Ninety-Eight Thousand Seven hundred and fifty-five) partly paid-up equity shares of the Company (“ Rights Equity Share(s) ”) which were allotted on June 19, 2024 on a right basis pursuant to Rs.10/- each in accordance with the Letter of Offer dated May 09, 2024.

The Applicants were required to pay ₹131.25/- [35% of the Issue Price of Rs. 375/- per equity share of FV of Rs. 10/- each (including a premium of Rs. 365/- per equity share)] per Equity Share on first call (₹ 3.50/- per Rights Equity Share and premium of ₹ 127.75/per Rights Equity Share).

In terms of Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, this is to further inform that the Record Date for the purpose of determining the holders of Rights Equity Shares to whom the call notice for the first call will be sent is Friday, April 04, 2025 and the details are as under:

==> picture [422 x 200] intentionally omitted <==

----- Start of picture text -----

Scrip Code / Scrip Code: 890202 / Symbol: SOLARAPP
ISIN ISIN: IN9624Z01014
Type of Partly paid-up Equity Shares
Security
Record Date Friday, April 04, 2025
Purpose For determining the holders of partly paid-up Equity Shares to
whom the call Notice for the first call of Rs. 3.75/- will be sent
Call Payment Opening Date: 16.04.2025
Period Closing Date: 30.04.2025 Both days inclusive
Period 15 days
Available to
pay
Acceptable a) Online ASBA
Mode of b) Physical ASBA
Payment c) 3- in- 1 online trading demat bank account
----- End of picture text -----

REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636

Communication Address: Solara Active Pharma Sciences Limited 2nd Floor, Admin Block 27, Vandaloor Kelambakkam Road, Keelakottaiyur Village, Melakottaiyur (Post) Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

The details in regard to the abovementioned matter and terms of Regulation 30 read with Schedule III - Para A (2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/ 2023/123 dated July 13, 2023 is enclosed as “ Annexure – I ”.

Further, details in relation to the call will be included in the first call notice that will be sent to the eligible equity shareholders of partly paid-up equity shares in due course.

We request you to take the same on record and the same be treated as compliance under the applicable provisions of the SEBI Listing Regulations, as amended.

The Rights Issue Committee Meeting commenced at 10.00 A.M. and concluded at 10:30 A.M.

Thanking you, Yours faithfully,

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2025.03.26 10:43:38 +05'30'

S. Murali Krishna Company Secretary & Compliance Officer Membership No.: A13372

Encl.: As above

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942

Communication Address:

Solara Active Pharma Sciences Limited 2nd Floor, Admin Block

27, Vandaloor Kelambakkam Road, Chennai – 600 127, India Tel: +91 44 43446700 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

Keelakottaiyur Village, Melakottaiyur (Post)

Annexure – I Details under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read along with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 read with Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/ 2023/123 dated July 13, 2023

==> picture [454 x 327] intentionally omitted <==

----- Start of picture text -----

Sr. Particulars Remarks
No.
1. Forfeiture of shares Not Applicable.
2. Reissue of forfeited shares or Not Applicable.
securities, or the issue of shares or
securities held in reserve for future
issue or the creation in any form or
manner of new shares or securities or
any other rights, privileges or benefits
to subscribe to
3. Proposal to issue any class of Not Applicable
securities;
4. Alterations of capital, including calls; The first call of ₹ 3.50/- each (i.e.) 35% on the
face value of Rs. 10/- each on the 1,19,98,755
(One Crore Nineteen Lakhs Ninety-Eight
Thousand Seven hundred and fifty-five) partly
paid-up equity shares of the Company at a
premium of Rs. 127.75/- aggregating to ₹157.48
Crores be made.
5. Change in the terms regarding Not Applicable
redemption/cancellation/retirement in
whole or in part of any securities
issued by the listed entity
----- End of picture text -----

For Solara Active Pharma Sciences Limited

SUDDAPALLI Digitally signed by SUDDAPALLI MURALIKRISHNA MURALIKRISHNA Date: 2025.03.26 10:44:35 +05'30'

S. Murali Krishna Company Secretary & Compliance Officer Membership No.: A13372

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636 REGD. OFF: 201, Devavrata, Sector 17, Vashi Navi Mumbai - 400703. India/ Tel: 91-22-2789 2924 / 2789 3199 / Fax: 91-22-2789 2942